Aurinia Pharmaceuticals
AUPH
#4602
Rank
NZ$3.57 B
Marketcap
NZ$27.10
Share price
0.38%
Change (1 day)
73.30%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2025 (TTM): NZ$0.14 Billion

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are NZ$0.26 Billion. In 2024 the company made an earning of NZ$21.22 Million, an increase over its 2023 earnings that were of -NZ$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.14 B579.19%
2024 NZ$21.22 M-116.44%
2023 -NZ$0.13 Billion-31.8%
2022 -NZ$0.19 Billion-39.4%
2021 -NZ$0.32 Billion61.9%
2020 -NZ$0.2 Billion-9.73%
2019 -NZ$0.22 Billion92.65%
2018 -NZ$0.12 Billion36.39%
2017 -NZ$81.34 Million106.29%
2016 -NZ$39.43 Million-15.4%
2015 -NZ$46.61 Million65.84%
2014 -NZ$28.11 Million129.82%
2013 -NZ$12.23 Million-26.6%
2012 -NZ$16.66 Million
2010 -NZ$9.44 Million-39.22%
2009 -NZ$15.52 Million-43.78%
2008 -NZ$27.61 Million-53.19%
2007 -NZ$58.98 Million42.97%
2006 -NZ$41.25 Million-23.03%
2005 -NZ$53.6 Million36.1%
2004 -NZ$39.38 Million172.57%
2003 -NZ$14.45 Million484.61%
2002 -NZ$2.48 Million
2000 -NZ$11.74 Million453.81%
1999 -NZ$2.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
NZ$8.89 B 6,020.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-NZ$9.49 Million-106.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
-NZ$38.23 Million-126.31%๐Ÿ‡บ๐Ÿ‡ธ USA